by | | Newsroom
We are thrilled to announce that Omnidermal Biomedics s.r.l. and PBL Srl have received the clearance for the commercialization of the new Emergency Ventilator ABU (Automatic Breathing Unit) within the European Union territory. ABU has been developed to address the...
by | | Newsroom
Clinical trials for clinical approval of the WoundViewer technology have ended. To find out more click on the link: https://pubmed.ncbi.nlm.nih.gov/33320742
by | | WeWin
Omnidermal Biomedics is strongly grateful to announce the award of the Emilia Romagna funding call to support research and innovation projects for the development of solutions aimed at contrasting of the COVID-19 epidemic. This grant was created to promote open...
by | | Newsroom
Omnidermal Biomedics is strongly grateful to announce the award of the Emilia Romagna funding call to support research and innovation projects for the development of solutions aimed at contrasting of the COVID-19 epidemic. This grant was created to promote open...
by | | WeWin
The #innovative Wound Viewer technology, designed and developed by Omnidermal Biomedics, has recently been awarded by two prestigious grants: Brevetti + Invitalia and Bando SC-UP Finpiemonte S.p.A..Brevetti+ is a public grant promoted by the Italian Ministry of...
Recent Comments